相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Many players in BCL-2 family affairs
Tudor Moldoveanu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis
Karin Simonin et al.
APOPTOSIS (2013)
PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells
Shudong Zhu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Latest research and treatment of advanced-stage epithelial ovarian cancer
Robert L. Coleman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Bcl-2-Enhanced Efficacy of Microtubule-Targeting Chemotherapy through Bim Overexpression: Implications for Cancer Treatment
Amandine Savry et al.
NEOPLASIA (2013)
Decoding and unlocking the BCL-2 dependency of cancer cells
Philippe Juin et al.
NATURE REVIEWS CANCER (2013)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
Andrew W. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells
Hong Zhu et al.
PLOS ONE (2012)
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
S. Cristofanon et al.
CELL DEATH & DISEASE (2012)
γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells
Celine Seveno et al.
BREAST CANCER RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
BIM Expression in Treatment-Naive Cancers Predicts Responsiveness to Kinase Inhibitors
Anthony C. Faber et al.
CANCER DISCOVERY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Mcl-1; the molecular regulation of protein function
Luke W. Thomas et al.
FEBS LETTERS (2010)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
Bcl-2 Modulation to Activate Apoptosis in Prostate Cancer
Kevin Bray et al.
MOLECULAR CANCER RESEARCH (2009)
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
Karin Simonin et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
Paula Hauck et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Anthony C. Faber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines:: Mcl-1 inactivation
Min H. Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Absence of Bcl-X-L down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells
M. Villedieu et al.
GYNECOLOGIC ONCOLOGY (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Expression of Bcl-XL in ovarian carcinoma is associated with chemoresistance and recurrent disease
J Williams et al.
GYNECOLOGIC ONCOLOGY (2005)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide
AP Simoes-Wüst et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas
K Shigemasa et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
分享论文
